CTI BioPharma Corp. carries a market capitalization of 1.20B, placing it among publicly traded companies globally.
| Market Cap | 1.20B |
| Enterprise Value | N/A |
CTI BioPharma Corp.'s stock has gained approximately 50.33058% over the past 52 weeks. The 50-day moving average sits at 7.34, while the 200-day moving average is 5.86.
| Beta (5Y) | N/A |
| 52-Week Price Change | 50.33058% |
| 50-Day Moving Average | 7.34 |
| 200-Day Moving Average | 5.86 |
| Average Volume (20 Days) | N/A |
CTI BioPharma Corp.'s most recent stock split took place on January 3, 2017 with a 10:1 split ratio.
| Last Split Date | 1/3/2017 |
| Split Ratio | 10:1 |